|
|
||||||||
Full Scientific Reports |
Correspondence: 1Corresponding Author: Shangjin Cui, National Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, 427 Maduan Street, Nangang District, 150001 Harbin, China. cuishangjin{at}yahoo.com.cn
| Abstract |
|---|
|
|
|---|
Key Words: Avian influenza virus colloid gold test strip H5 subtype monoclonal antibody
| Introduction |
|---|
|
|
|---|
The most common methods for detecting AIV-H5 include virus isolation, hemagglutination (HA)/hemagglutination inhibition (HI) test, reverse transcription polymerase chain reaction (RT-PCR), fluorescent quantitative PCR, and digoxin-labeled probe detection.3,11 These methods, however, require relatively sophisticated laboratories, which are sometimes unavailable or inconvenient for clinical application.6 In contrast, the colloidal gold test strip method provides rapid results but does not require sophisticated tools or special skills.10 The colloidal gold test strip is a new immunochromatographic technique in which a cellulose membrane is used as the carrier, and a colloidal gold-labeled antigen or antibody is used as the tracer. This technology has several advantages over traditional immunoassays, such as simplicity of procedure, rapid operation, immediate results, low cost, and no requirements for skilled technicians or expensive equipment. Because of these characteristics, the colloidal gold test strip is suitable for the on-site detection of antibodies or antigens. The technology has been adapted for the surveillance and diagnosis of poultry infectious diseases, such as Newcastle disease and infectious bursal disease. Although a chromatographic strip test for rapid detection of nucleocapsid protein of AIV has also been developed based on this method,9 a strip test specific for the H5 subtype of AIV has not been reported.
In the present study, 4 strains of anti–AIV-H5 antibodies were prepared, and an immune strip test for detecting AIV-H5 was developed. This strip test, which uses chromatographic technique and colloidal gold, provides a fast and sensitive detection tool for the diagnosis and epidemiological investigation of AIV-H5 and also provides a good foundation for the development of a final product. Because multiple lineages of H5 viruses (including Chicken Scotland, low pathogenicity strains, and other currently endemic strains) were unavailable, the reliability of the strip has only been demonstrated for the lineage of H5N1 investigated in the current study. The reliability of the strip test for other strains remains to be determined.
| Materials and Methods |
|---|
|
|
|---|
Monoclonal Antibody Preparation
Subtype H5N1 of AIV, which was cultured in chicken embryo, was purified with a sucrose density gradient as previously described.14 For the subcutaneous multiple injections into the backs of mice, the virus was emulsified with an equal volume of Freund's complete adjuvant, and each mouse received approximately 80 µg of virus. The splenocytes from immunized mice were fused with SP2/0 cells at the logarithmic phase by treatment with PEG (MW6000). The hybridomas secreting monoclonal antibodies (mAbs) were selected by indirect ELISA. Large quantities of mAbs were prepared with the mouse ascites method. Monoclonal antibodies were purified using a protein G perfusion affinity chromatographic column. The purified mAbs were dialyzed in 10 mmol/l phosphate buffered saline (PBS). After dialysis, the protein concentration was determined with an ultraviolet spectrophotometer at 280 nm, and the preparation was cryopreserved in aliquots of 0.5 ml.
Determination of Mab Titer
The titer of the 4 mAbs was determined by indirect ELISA.7,18 The supernatant culture of hybridomas and crude ascites was diluted in a gradient from 1:10 to 1:100. The same diluted supernatant of SP2/0 cell culture and normal ascites was used as the negative control. Enzyme label plates coated with one kind of antigen (H5N1 antigen, AIV H1–H14 standard antigen, or antigens of NDV, IBDV, IBV, or AILV) were used to determine the specificity of the 4 mAbs.
Preparation of Polyclonal Antibody
Three New Zealand white rabbits were intramuscularly injected with purified H5N1 virus (0.5 mg/rabbit) mixed with Freund's complete adjuvant in a 1:1 ratio. Rabbits were subsequently injected 3 more times with the same volume every 3 weeks. One week after the fourth injection, rabbit antisera were collected.
Colloidal Gold Preparation, Ratio of Colloidal Gold to Coated Antibodies, and Labeling Procedure
The colloidal gold (diameter of 20 nm) was prepared with a sodium citrate reduction method as previously described.13 Colloidal gold fluid was adjusted to pH 8.2 with 0.2 mol/l of K2CO3. The high-titer and high-affinity mAb 3C4 (7 µg/ml) was added to 20 ml of colloidal gold, followed by 5% bovine serum albumin (BSA) to provide a final concentration of 1%. The precipitate was discarded after centrifugation at 1,000 x g for 20 min; the supernatant was discarded after centrifugation at 11,000 x g for 40 min. The precipitate was resuspended with colloidal gold fluid to a volume of 1 ml (optical density at 520 nm (OD520) =
0.25), and 0.5 mg/ml sodium azide was then added. The preparation was stored at 4°C.
The mAb 3C4 with conjugated colloidal gold was sprayed onto a glass fiber pad at 1.0 and 1.5 µl/cm, then dried at 40°C overnight. The combination of mAb 1A6 and rabbit anti-H5N1 antibody (1:1, 1 mg/ml) was microsprayed onto a nitrocellulose membrane (1 µl/cm) at a position that would become the capture test line (T) of the completed strip. Goat antimouse IgG antibody in PBS (1 mg/ml) was microsprayed onto the same nitrocellulose membrane (1 µl/cm) at a position that would become the capture control line (C). The membrane was dried at 40°C overnight.
Test Strip Package
To assemble a package or kit, the nitrocellulose membrane was arranged with mAb 3C4 conjugated with colloidal gold at one end, upstream of the test line, and an absorbing pad at the opposite end, downstream from the control line. Then, the assembly was cut into 3 x 60 mm strips. Each strip was placed in a plastic case, which was individually stored in a desiccated plastic bag.
Specificity, Sensitivity, Stability, and Tests with Clinical Specimens
Specificity of the colloidal gold strip test was determined with H5N1 chicken embryonic culture, normal chicken allantoises fluid, standard antigens of AIV H1–H14, and antigens of NDV, IBDV, IBV, and AILV (for results, see Fig. 1). A pipet was used to add the sample or allantoic fluid to the sample pad, which was then placed on a horizontal surface for 5–20 min before the strip was examined for bands. The results were determined by band number and position. Positive specimens yielded 1 band at the control line and 1 band at the test line, whereas negative specimens yielded 1 band at the control line and no band at the test line (Fig. 2). The test results were discarded if there was no band at the control line.17
To determine sensitivity, the H5N1 embryonated egg culture with known HA titer was 10-fold serially diluted, and the dilutions were tested with the colloidal gold strip, HA/HI test, and RT-PCR. To determine stability, strips that had been stored for 3, 6, 9, 12, 15, and 18 months at 4°C were tested with H5N1-positive and -negative specimens. At each sample time, 30 strips were tested. To determine how the strip test performed with clinical samples, 483 clinical specimens (cloacal swabs) suspected of having H5N1 infection were simultaneously subjected to the colloidal gold strip test, HA/HI test, RT-PCR, and Anigen H5 AIV Ag ELISA.
| Results |
|---|
|
|
|---|
Specificity of Mabs
Specificity of the 4 mAbs was determined by ELISA. The mAbs 1A6 and 3C4 were highly specific; they reacted with H5N1 virus and AIV-H5, but did not cross react with other subtypes of AIV or the antigens of NDV, IBDV, IBV, or AILV.
Specificity of the Immune Colloid Gold Test Strip
H5N1 allantoic fluid, standard antigen of AIV H1–H14, and virulent and normal allantoic fluid of NDV, IBDV, IBV, AILV, Marek's disease virus, and AIV-H9 were tested on the strip. The results were positive for allantoic fluid of H5N1 and standard antigen of AIV-H5 but were negative for the other antigens, indicating that the test strip was highly specific.
Sensitivity of the Immune Colloid Gold Test Strip
One milliliter of the allantoic fluid of H5N1 with HA titer of 1:27 was serially diluted, and 50 µl of each diluted sample was added to test strips. The band appeared at the test line with all dilutions less than 1:1,000, but no band appeared when the dilution was 1:1,000 or greater. This sensitivity was similar to that with the HA/HI test, but lower compared with RT-PCR, which detected the virus at a minimal dilution of 1:10,000.
Stability of Immune Colloid Gold Strips
Strips that were stored for 3, 6, 9, 12, 15, 18, and 24 months at 4°C were tested with known H5N1-positive and -negative specimens to determine strip stability. All test results were the same from 3 to 15 months, with all known positives testing positive and all known negatives testing negative. After 18 months, however, 15% of the known positives tested negative, and after 21 months, 30% of the known positives tested negative. False positives were never detected.
Tests with Clinical Specimens
Cloacal swabs from 483 birds suspected of having AIV-H5 infection were handled according to the Manual of Standards for Diagnostic Tests and Vaccines.19 The swabs were treated with 3 ml of PBS (10,000 U/ml of penicillin, 10 mg/ml of streptomycin, 5,000 U/ml of streptomycin) for 1 hr at room temperature. After centrifugation at 1,000 x g for 10 min, the supernatant was inoculated into the allantoic cavities of 9–11-day-old SPF embryonic eggs. After incubation at 37°C for 7 days, the allantoic fluid of each egg was subjected to the immune colloidal gold strip, HA/HI test, RT-PCR, and the Anigen H5 AIV Ag ELISA. The results from the immune colloidal gold strip agreed with those from the HA/HI test and the Anigen H5 AIV Ag ELISA. Results of the RT-PCR, which used the primers of the HA gene of AIV-H5, also agreed with those of the strip test, with 1 exception (Table 1).
|
| Discussion |
|---|
|
|
|---|
The key to differentiating subtypes of AIV with the immune colloidal gold test strip method is obtaining H5 subtype–specific mAb. In the current study, purified chicken embryonic culture containing H5N1 influenza virus was injected into mice, and 4 H5 subtype–specific mAbs were obtained by screening with ELISA plates that had been coated with different subtypes of AIV antigens. The specificity of the test strip was verified during the experiment in that the results were positive only for H5N1 virus and AIV-H5 standard antigens. This indicates that the test strip can be used to differentiate AIV-H5 from other subtypes of AIV and the antigens of NDV, IBDV, IBV, and AILV.
The results obtained with 483 clinical specimens suspected of having H5N1 AIV infection showed that detection of H5N1 was similar with the HA/HI test and the colloidal gold test strip. In addition, total RNA was extracted from the 483 specimens, and RT-PCR amplification was conducted using the primers of the AIV-H5 HA gene. The amplification results were again consistent with those of the colloidal gold test strip in all but 1 case. All of these results suggest that the test strip prepared in the current study could be used in the specific diagnosis and epidemiological investigation of AIV-H5. Owing to a limited availability of specimens, further research is needed to verify that the AIV-H5 test strip does not produce positive results with other subtypes of AIV. Determining whether the strip test produces reliable results with multiple lineages of H5 viruses (only 1 lineage was used in the current study) will require additional research.![]()
|
|
| Acknowledgments |
|---|
| Sources and manufacturers |
|---|
|
|
|---|
a. Animal Genetics Inc., Gyeonggi-do, Korea. ![]()
b. Shanghai Sangon Biological Engineering Technology & Services Co., Shanghai, China. ![]()
c. Millipore Corp., Billerica, MA. ![]()
d. Sigma-Aldrich China Inc., Shanghai, China. ![]()
e. Invitrogen Corp., Carlsbad, CA. ![]()
f. Amersham Health Inc., Princeton, NJ. ![]()
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H.-T. Ho, H.-L. Qian, F. He, T. Meng, M. Szyporta, N. Prabhu, M. Prabakaran, K.-P. Chan, and J. Kwang Rapid Detection of H5N1 Subtype Influenza Viruses by Antigen Capture Enzyme-Linked Immunosorbent Assay Using H5- and N1-Specific Monoclonal Antibodies Clin. Vaccine Immunol., May 1, 2009; 16(5): 726 - 732. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |